News
-
-
PRESS RELEASE
Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Andera Partners' portfolio company Tubulis acquired by Gilead, strengthening Gilead's oncology pipeline with innovative ADC technology -
-
-
-
-
-
PRESS RELEASE
Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Predictiv AI files patent application for domain-specific clinical AI reasoning platform to support medical decision-making. Approach focuses on cost efficiency, data privacy, and structured reasoning for clinicians -
-